Sign in

Cognizant Technology Solutions Corporation CTSH

Price 64.6 USD
as of 2026-09-05
64/100
Mixed
Quality63
Growth62
Balance-sheet strength78
Valuation77
Momentum38
Income61

Composite 64/100; the shares have moved about 46% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 38/100 — a moderate mark against it.

Case for

Balance-sheet strength ranks 78/100 — a strong point in its favour. Valuation ranks 77/100 — a strong point in its favour. Quality ranks 63/100 — a moderate point in its favour.

Case against

Momentum ranks 38/100 — a moderate mark against it.

What the company does Cognizant provides IT consulting, outsourcing, and AI-led automation services across financial services, health sciences, products and resources, and communications/media/technology. Its offerings include advisory, application development, systems integration, and AI-driven customer experience solutions.

Key financials ROE 14.9%, ROA 10.7%, gross margin 33.4%, operating margin 17.5%, net margin 10.3%. Revenue growth 7.0%, EPS growth 2.6%. Debt/equity 0.14, current ratio 2.18. Dividend yield 2.1%, payout 23.6%.

Stock health Sideravia overall score 63.5 (average quality, attractively valued). Quality 62.1, Growth 61.8, Strength 75.8, Valuation 73.5, Momentum 38.8, Income 60.2. Piotroski F-Score 7/9.

Price vs fair value CTSH trades at a discount of 0.30% versus the analyst mean target of 63.94. - CTSH’s stock may trade at a 44% discount despite fresh AI contract pressure (Simply Wall St.) - Recent AI R&D deal with Kyowa Kirin signals automation edge redefinition (Simply Wall St.) - Sector peers’ valuation gaps cited as context for CTSH’s positioning (Trefis)

Looking forward Forward P/E 10.70 and PEG 0.48 suggest valuation support, while revenue growth of 7.0% and FCF yield 7.7% indicate steady cash generation. Momentum remains weak with 12m -9.04% and RSI 73.30.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.